Study of LM11A-31-BHS in Mild-moderate AD Patients

Clinical trial NCT03069014 · COMPLETED

Trial details

NCT number: NCT03069014
Sponsor: PharmatrophiX Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mild to Moderate Alzheimer's Disease

Start date: 2017-02-15
Primary completion: 2020-06-08
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.